Compounds > valyl-glycyl-valyl-alanyl-prolyl-glycine
Page last updated: 2024-09-03

valyl-glycyl-valyl-alanyl-prolyl-glycine and Pulmonary Disease, Chronic Obstructive

valyl-glycyl-valyl-alanyl-prolyl-glycine has been researched along with Pulmonary Disease, Chronic Obstructive in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Ancel, J; Antonicelli, F; Audonnet, S; Deslée, G; Dury, S; Gaudry, P; Le Naour, R; Lebargy, F; Lemaire, F; Perotin, JM1

Trials

1 trial(s) available for valyl-glycyl-valyl-alanyl-prolyl-glycine and Pulmonary Disease, Chronic Obstructive

ArticleYear
The elastin peptide VGVAPG increases CD4
    Respiratory research, 2021, Jan-13, Volume: 22, Issue:1

    Topics: Adult; Aged; CD4-Positive T-Lymphocytes; Cells, Cultured; Female; Humans; Interleukin-4; Leukocytes, Mononuclear; Male; Middle Aged; Oligopeptides; Pulmonary Disease, Chronic Obstructive

2021